Lucro Operacional Alterar Data
Adma Biologics USD 51.01M 8.21M 2025-09
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
BioCryst Pharmaceuticals USD -2.54M 10.23M 2024-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Novavax USD -134.02M 296.12M 2024-09
Omeros USD -35.41M 23.75M 2024-09
Takeda JPY 168.82B 479.89B 2025-12